Hedlund Po

INTRAVESICAL CHEMOTHERAPY AND IMMUNOTHERAPY: HOW DO WE ASSESS THEIR EFFECTIVENESS AND WHAT ARE THEIR LIMITATIONS AND USES?

Lamm Dl, APM van de Meijden, Hideyuki Akaza et al. · International Journal of Urology · 1995 · 64 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients.

Hedlund Po, H. Gustafson, S. Sjögren · PubMed · 1980 · 62 citations

Medicine, Endocrinology, Oncology +15

Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.

L. Andersson, T. Berlin, Jenny Hernestål Boman et al. · PubMed · 1980 · 28 citations

Medicine, Oncology, Urology +17

Postoperative venous thrombosis in benign prostatic disease. A study of 316 patients, using the 125I-fibrinogen uptake test.

Hedlund Po · PubMed · 1975 · 28 citations

Medicine, Surgery, Urology +15